肉毒杆菌素瘦脸（咬肌肥大）
皮肤美容
≈ ¥2000-4000
(≈ $280-570)
大约15-30分钟
免责声明：本站为医疗服务机构，页面信息部分由AI协助制作。健康相关信息不构成医疗建议。如有任何疑问，请咨询医疗专业人士。详情见免责声明
项目介绍
肉毒杆菌素瘦脸（咬肌肥大）在一般公立医院参考费用约¥1400-3200，三甲医院参考费用约¥2000-4000，常用于相关诊断评估与就医安排，费用随医院及地区有所差异。
主要用途
Primary clinical use is the aesthetic reduction of enlarged masseter muscles causing square or widened lower face contour ('masseteric hypertrophy'). Indications include: 1) Symptomatic bruxism-related masseter hypertrophy with jaw discomfort or dental wear, 2) Cosmetic contouring for facial harmonization in patients with prominent mandibular angles, 3) Adjunctive management in temporomandibular joint (TMJ) disorders where masseter hyperactivity contributes to pain or dysfunction (off-label), 4) Diagnostic therapeutic trial to confirm masseter-driven facial widening when differential diagnosis includes bony hypertrophy or parotid enlargement.
正常值范围
Not applicable — botulinum toxin injection for masseter hypertrophy is a cosmetic therapeutic procedure, not a laboratory test with numerical biomarkers or quantifiable 'values'. There is no standardized 'normal range' for efficacy, dosage, or physiological parameters; clinical assessment relies on subjective and objective evaluation of facial symmetry, muscle bulk reduction (measured via calipers or ultrasound pre/post), and patient-reported outcomes.
偏低可能原因
N/A — 'low values' do not apply, as this is not a diagnostic assay. However, suboptimal clinical response (e.g., insufficient masseter reduction) may result from: 1) Underdosing relative to muscle mass, 2) Inaccurate injection placement (e.g., targeting superficial vs. deep masseter), 3) Presence of compensatory muscle hyperactivity (e.g., temporalis overuse), 4) Individual pharmacokinetic variability (e.g., rapid antibody formation in rare cases), 5) Early post-injection assessment (<2–4 weeks before full neuromuscular effect manifests).
偏高可能原因
N/A — 'high values' are not defined for this procedure. Excessive or unintended effects (e.g., excessive muscle atrophy, facial hollowing, or dysphagia) may arise from: 1) Overdosing beyond recommended units (typically >50–60 U per side for average adults), 2) Diffusion of toxin into adjacent muscles (e.g., zygomaticus, lateral pterygoid, or mandibular branch of facial nerve), 3) Use of non-FDA/EMA-approved or counterfeit botulinum toxin products with inconsistent potency, 4) Pre-existing neuromuscular disorders (e.g., myasthenia gravis, Lambert-Eaton syndrome), 5) Concurrent use of aminoglycoside antibiotics or muscle relaxants potentiating neuromuscular blockade.